Home R&D Page 12

R&D

Clinical trials. Which patients do we include?

We are moving towards a drug development approach patient focused. Can we offer new innovative therapies to severe patients and ethnic minorities?

Lamivudine and raltegravir together to treat HIV

Pegfilgrastim against tumor side effects

Talimogene laherparepvec in metastatic melanoma

SARIL-RA-TARGET results on rheumatoid arthritis

Nicholas A. Peppas

Excellence in drug delivery

The famous scientist has a long history of innovation in biomedical engineering, drug delivery and controlled release systems. He has been awarded the Giulio Natta Medal in Chemical Engineering by the Politecnico of Milan
Rare diseases

Challenges in place for therapy

By the 2020, drugs are expected to account for 19% of the total share of prescription drug sales

A monoclonal antibody to treat psoriasis

The first stem cell treatment approved in EU is made in...

First results on favipiravir against Ebola

1...111213...17Page 12 of 17
© © 2025 Tecniche Nuove Spa - All rights reserved. Registered office: Via Eritrea 21 - 20157 Milan. Share capital: 5,000,000 Euro fully paid up. Tax code, VAT number and registration with the Milan Register of Companies: 00753480151